SEC Form 4Coverage since Jun 1, 2026
$OBIO insider trading
Over the last 12 months, Orchestra BioMed Holdings insiders reported 1 buy totaling $19K and 3 sales totaling $183K across SEC Form 4 filings. 75% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $19K 1 event
- Sold · 12m
- $183K 3 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 75% pre-arranged plans
Side
Price · $OBIO · 12Mvia TradingView
Top insiders · 12m
Sherman DarrenSee Remarks3× · $183K
Hochman David PSee Remarks1× · $19K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Sherman DarrenSee Remarks · O·D | ▼ Sale | 15,000 | $4.09 | $61K | -1.3% | plan |
| Jul 1, 2026 | Sherman DarrenSee Remarks · O·D | ▼ Sale | 15,000 | $4.27 | $64K | -1.3% | plan |
| Jun 1, 2026 | Hochman David PSee Remarks · O·D | ▲ Buy | 5,000 | $3.83 | $19K | +0.5% | — |
| Jun 1, 2026 | Sherman DarrenSee Remarks · O·D | ▼ Sale | 15,000 | $3.87 | $58K | -1.3% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $OBIO feed.